Koyfin Home > Directory > Health Care > Aldeyra Therapeu > Capital Expenditures

Aldeyra Therapeu Capital Expenditures Chart (ALDX)

Aldeyra Therapeu annual/quarterly Capital Expenditures from 2014 to 2019.
  • Aldeyra Therapeu Capital Expenditures for the quarter ending December 12, 2019 was $0m a 0.00% increase of 0m year over year
  • Aldeyra Therapeu Capital Expenditures for the last 12 months ending June 06, 2020 was $0m a 0.00% increase of 0m year over year
  • Aldeyra Therapeu Annual Capital Expenditures for 2019 was $0m a -2,659.64% increase of 0m from 2018
  • Aldeyra Therapeu Annual Capital Expenditures for 2018 was $0m a 90.58% decrease of 0m from 2017
  • Aldeyra Therapeu Annual Capital Expenditures for 2017 was $0m a 52.30% decrease of 0m from 2016
Other Cash Flow Metrics:
  • Aldeyra Therapeu Cash Flow from Operations for the quarter ending September 09, 2018 was $-8m a 34.73% decrease of -3m year over year
  • Aldeyra Therapeu Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $2m a 206.88% increase of 5m year over year
View Chart On Koyfin

Quarterly ALDX Capital Expenditures Data

12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$0m
12/2017$0m
09/2017$0m

Annual ALDX Capital Expenditures Data

2019$0m
2018$0m
2017$0m
2016$0m
2015$0m
2014$0m